Drug profile · INN
tarlatamab-dlle
IMDELLTRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tarlatamab-dlle (IMDELLTRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN tarlatamab-dlle
Brand IMDELLTRA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is tarlatamab-dlle?
tarlatamab-dlle (IMDELLTRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tarlatamab-dlle?
IMDELLTRA is a marketed brand name for tarlatamab-dlle. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tarlatamab-dlle?
tarlatamab-dlle has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.